{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:46:08Z","timestamp":1764175568482,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.trim.2023.101978","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T12:13:05Z","timestamp":1706616785000},"page":"101978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy and safety in early application of Ruxolitinib for high-risk acute lymphoblastic leukemia to prevent GVHD and recurrence after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"83","author":[{"given":"Qian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feiyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.trim.2023.101978_bb0005","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/cncr.29383","article-title":"New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia[J]","volume":"121","author":"Jabbour","year":"2015","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.trim.2023.101978_bb0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.6004\/jnccn.2021.0042","article-title":"Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology[J]","volume":"19","author":"Brown","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"9","key":"10.1016\/j.trim.2023.101978_bb0015","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","article-title":"Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies[J]","volume":"120","author":"Gokbuget","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.trim.2023.101978_bb0020","first-page":"529","article-title":"Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease -acute graft-versus-host disease (2020)","volume":"41","author":"Stem Cell Application Group C S O H C M A","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.trim.2023.101978_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2018.08.030","article-title":"The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China[J]","volume":"438","author":"Wang","year":"2018","journal-title":"Cancer Lett."},{"issue":"6","key":"10.1016\/j.trim.2023.101978_bb0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/2040620713489842","article-title":"Treatment and management of graft-versus-host disease: improving response and survival[J]","volume":"4","author":"Garnett","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.trim.2023.101978_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13045-014-0059-3","article-title":"Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG)[J]","volume":"vol. 7","author":"Lai","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.trim.2023.101978_bb0040","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.bbmt.2016.09.007","article-title":"Comparison of cyclophosphamide combined with total body irradiation, oral Busulfan, or intravenous Busulfan for allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemia[J]","volume":"22","author":"Mitsuhashi","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101978_bb0045","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1634\/theoncologist.2019-0627","article-title":"FDA approval summary: ruxolitinib for treatment of steroid-refractory acute graft-versus-host disease[J]","volume":"25","author":"Przepiorka","year":"2020","journal-title":"Oncologist"},{"issue":"6","key":"10.1016\/j.trim.2023.101978_bb0050","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.bbmt.2017.12.797","article-title":"The role of Janus kinase signaling in graft-versus-host disease and graft versus leukemia[J]","volume":"24","author":"Schroeder","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.trim.2023.101978_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbmt.2018.09.003","article-title":"Ruxolitinib as salvage therapy for chronic graft-versus-host disease[J]","volume":"25","author":"Modi","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.trim.2023.101978_bb0060","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1016\/j.bbmt.2020.01.012","article-title":"Calcineurin inhibitors replacement by ruxolitinib as graft-versus-host disease prophylaxis for patients after allogeneic stem cell transplantation[J]","volume":"26","author":"Zhao","year":"2020","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.trim.2023.101978_bb0065","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/EDBK_280175","article-title":"Recent advances in managing acute lymphoblastic leukemia[J]","volume":"40","author":"Deangelo","year":"2020","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"issue":"24","key":"10.1016\/j.trim.2023.101978_bb0070","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.scib.2021.06.002","article-title":"Optimizing antithymocyte globulin dosing in haploidentical hematopoietic cell transplantation: long-term follow-up of a multicenter, randomized controlled trial[J]","volume":"66","author":"Wang","year":"2021","journal-title":"Sci. Bull. (Beijing)"},{"issue":"1","key":"10.1016\/j.trim.2023.101978_bb0075","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1038\/s41598-021-88080-3","article-title":"Ruxolitinib early administration reduces acute GVHD after alternative donor hematopoietic stem cell transplantation in acute leukemia[J]","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.trim.2023.101978_bb0080","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey[J]","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327423001958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:04:49Z","timestamp":1760810689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327423001958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":16,"alternative-id":["S0966327423001958"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101978","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety in early application of Ruxolitinib for high-risk acute lymphoblastic leukemia to prevent GVHD and recurrence after allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101978"}}